Table 2.

Median 3-year survival (IQR) under conservative versus interventional therapies including all patients with cholangiocarcinoma.

Therapy	Total (n)	Median survival (months)	Significance (P)
OP	61	27.1 (14.9)
No OP	121	10.0 (15.1)	<.001
Adjuvant chemotherapy	14	33.4 (27.1)
No adj. chemo	47	26.6 (14.9)	.49
Chemotherapy	136	17.4 (20.4)
No chemotherapy	33	8.2 (3)	.466
PDT	14	19.3 (19.4)
No PDT	166	15.5 (27.3)	.488
TACE	18	22.0 (16.7)
No TACE	162	14.5 (22.8)	.190